Tyrosinase-Induced Phenoxyl Radicals of Etoposide (VP-16): Interaction with Reductants in Model Systems, K562 Leukemic Cell and Nuclear Homogenates

References

• Slevin M. L. The clinical pharmacology of etoposide. Cancer 1991; 67: 319–329
   PubMed Web of Science ®Google Scholar
• Osheroff N. Biochemical basis for the interaction of type I and type II topoisomerases with DNA. Pharmacology and Therapeutics 1989; 41: 223–241
   PubMed Web of Science ®Google Scholar
• Loike J. D., Horwitz S. B. Effect of VP-16–213 on the intracellular degradation of DNA in HeLa cells. Biochemistry 1976; 15: 5443–5448
   PubMed Web of Science ®Google Scholar
• Sinha B., Trush M. Free radical metabolism of VP-16 and inhibition of anthracycline-induced lipid peroxidation. Biochemical Pharmacology 1983; 32: 3495–3498
   PubMed Web of Science ®Google Scholar
• Van Maanen J. M.S., Retel J., de Vries J., Pinedo H. M. Mechanisms of action of antitumor drug etoposide: a review. Journal of the National Cancer Institute 1988; 80: 1526–1533
   PubMed Web of Science ®Google Scholar
• Haim N., Nemec J., Roman J., Sinha B. Peroxidase-catalyzed metabolism of Etoposide (VP-16–213) and covalent binding of reactive intermediates to cellular macromolecules. Cancer Research 1991; 47: 5835–5840
   Google Scholar
• Van Maanen J. M.S., De C.Ruiter de Vries J., Kootstra P. R., Gobass F., Pinedo H. M. The role of metabolic activation by cytochrome P-450 in covalent binding of VP 16–213 to rat liver and HeLa cell microsomal proteins. European Journal of Clinical Oncology 1985; 21: 1099–1106
   Web of Science ®Google Scholar
• Sinha B. K., Antholine W. M., Kalyanaraman B., Eliot H. M. Copper ion-dependent oxy-radical mediated DNA damage from dihydroxy derivative of etoposide. Biochimica et Biophysica Acta 1990; 1096: 81–83
   PubMed Web of Science ®Google Scholar
• Usui N., Sinha B. K. Tyrosinase-induced free radical formation from VP-16,213: relationship to cytotoxicity. Free Radical Research Communications 1991; 10: 287–293
   Google Scholar
• Sinha B. K., Politi P. M., Eliot H. M., Kerrigan D., Pommier Y. Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide. European Journal of Cancer 1990; 26: 590–593
   PubMed Web of Science ®Google Scholar
• Packer J. E., Slater T. F., Wilson R. L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 278: 737–738
   PubMed Web of Science ®Google Scholar
• Kagan V. E., Serbinova E. A., Packer L. Generation and recycling of radicals from phenolic antioxidants. Archives of Biochemistry and Biophysics 1990; 280: 33–39
   PubMed Web of Science ®Google Scholar
• Kagan V. E., Freisleben H.-J., Tsuchiya M., Forte T., Packer L. Generation of probucol radicals and their reduction by ascorbate and dihydrolipoic acid in human low density lipoproteins. Free Radical Research Communications 1991; 15: 273–284
   Google Scholar
• Maguire J. J., Kagan V. E., Ackrell B. A.C., Serbinova E. A., Packer L. Succinate-ubiquinone reductase linked recycling of a-tocopherol in reconstituted systems and mitochondria: requirement for reduced ubiquinone. Archives of Biochemistry and Biophysics 1992; 292: 47–53
   PubMed Web of Science ®Google Scholar
• Filipski J., Kohn K. W. Ellipticine-induced protein-associated DNA breaks in isolated L1210 nuclei. Biochimica et Biophysica Acta 1982; 698: 28–286
   Google Scholar
• Werkhoven-Goewie C. E., Brinkman U. A.T. Automated liquid chromatographic analysis of the antitumoprigenic drugs etoposide (VP 16–213) and teniposide (VM 26). Journal of Chromatography 1983; 276: 349–357
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B., Nemec J., Sinha B. K. Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR study. Biochemistry 1989; 28: 4839–4846
   PubMed Web of Science ®Google Scholar
• Li A. S., de Haas A. H., Chignell C. F., Motten A. G. Superoxide dismutase amplifies dye-photosensitized production of desferal free radical: an electron spin resonance study. Biochemical and Biophysical Research Communications 1989; 160: 1055–1060
   PubMed Web of Science ®Google Scholar
• Sinha B. K., Haim N., Dusre L., Kerrigan D., Pommier Y. DNA strand breaks produced by VP-16–213 in sensitive and resistant human breast tumor cells: implications for the mechanism of action. Cancer Research 1988; 48: 5096–5100
   PubMed Web of Science ®Google Scholar
• Mans D. R.A., Retel J., Van Maanen J. M.S., Lafleur M. V.M., Van Shaik M. A.H., Pinedo M., Lankelma J. Role of semiquinone free radical of the antitumour agent etoposide (VP-16–213) in the inactivation of single-and double-stranded ΦX 174 DNA. British Journal of Cancer 1990; 62: 54–60
   PubMed Web of Science ®Google Scholar
• Yalowich J. C., Stoyanovsky D. A., Allan W. P., Day B. W., Kagan V. E. Potentiation of etoposide (VP-16)-induced activity in the presence of the free radical initiator, 2,2′-azobis (2,4-dimethyl-valeronitrile), in human leukemia K562 cells. Proceedings of the American Association for Cancer Research 1993; 34: 1797
   Google Scholar
• Katki A. G., Kalyanaraman B., Sinha B. K. Interactions of the antitumor drug, etoposide, with reduced thiols in vitro and in vivo. Chem-Biol Interactions 1987; 62: 237–247
   PubMed Web of Science ®Google Scholar
• Rao R. D.N., Fischer V., Mason R. P. Glutathione and ascorbate reduction of the acetoaminophene radical formed by peroxidase. Journal of Biological Chemistry 1990; 265: 844–847
   PubMed Web of Science ®Google Scholar
• Bisby R. H., Parker A. W. Reactions of the α-tocopheroxyl radical in micellar solutions studied by nanosecond laser flash photolysis. FEBS Letters 1991; 290: 205–208
   PubMed Web of Science ®Google Scholar
• Crook T. R., Souhami R. L., Whiman G. D., McLean A. E.M. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Research 1986; 46: 5035–5038
   PubMed Web of Science ®Google Scholar
• Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radical Biology and Medicine 1993; 14: 325–337
   PubMed Web of Science ®Google Scholar
• Meister A., Anderson M. E. Glutathione. Annual Review of Biochemistry 1983; 52: 711–760
   PubMed Web of Science ®Google Scholar
• Mans D. R.A., Lafleur M. V.M., Westmijze E. J., Horn I. R., Bets D., Shuurhius G. J., Lankelma J., Retel J. Reactions of glutathione with the catechol, the ortho-quinone and the semiquinone free radical of etoposide. Biochemical Pharmacology 1992; 43: 1761–1768
   PubMed Web of Science ®Google Scholar
• Van Ommen B., Koster A., Verhagen H., Van Bladeren P. J. The glutathione conjugates of tert-butyl hydroquinone as potent redox cycling agents and possible redox reactive agents underlying the toxicity of butylated hydroxyanisole. Biochemical and Biophysical Research Communications 1992; 189: 309–314
   PubMed Web of Science ®Google Scholar
• Rousseau-Richard C., Auclair C., Richard C., Martin R. Free radical scavenging and cytotoxic properties in the ellipticine series. Free Radical Biology and Medicine 1990; 8: 223–230
   PubMed Web of Science ®Google Scholar